Skip to main content

Table 5 Distribution for scores and selected factors associated with breast cancer progression.

From: Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression

Scorea Total Non-HT Tissue visfatin > 50% LN metastasis Stage III, IV Age > 50 years Tumor size ≥ 2 cm
(n = 39) (n = 50) (n = 40) (n = 22) (n = 49) (n = 57)
nb nc % nc % nc % nc % nc % nc %
≤ 2 56   1 1.8 2 3.6   1 1.8  
3 21 2 9.5 2 9.5 2 9.52   2 9.52 2 9.52
4 14 5 35.7 5 35.7 3 21.4 4 28.6 5 35.7 6 42.9
≥ 5 14 8 57.1 9 64.3 8 57.1 7 50.0 8 57.1 9 64.3
  1. aCumulative score (Table 4) representing the number of risk properties of the selected clinicopathologic factors (HT, tissue visfatin, LN metastasis, stage, age, and tumor size) in patients
  2. bn is the number of all breast cancer patients with disease-free or progressed conditions
  3. cn is the number of breast cancer progressed patients